• Publications
  • Influence
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
An international group of experts in pharmacokinetic modeling recommends a consensus nomenclature to describe in vivo molecular imaging of reversibly binding radioligands.
  • 1,594
  • 83
Cardiac resynchronization therapy: Part 1--issues before device implantation.
Cardiac resynchronization therapy (CRT) has been used extensively over the last years in the therapeutic management of patients with end-stage heart failure. Data from 4,017 patients have beenExpand
  • 483
  • 14
Performance of the new generation of whole-body PET/CT scanners: Discovery STE and Discovery VCT
PurposeThe new GE Discovery STE and Discovery VCT respectively combine 16-slice and 64-slice CT with PET. The PET scanner has a new BGO detector block of 8×6 matrix (6.3×4.7×30 mm3). The aim of thisExpand
  • 146
  • 14
Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels.
CONTEXT AND OBJECTIVE Ectopic fat accumulation within and around the myocardial wall has been implicated in the pathogenesis of heart disease in obesity. We evaluated myocardial and epicardial fat,Expand
  • 275
  • 13
Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.
AIMS To assess the efficacy and safety of bone marrow cell (BMC) therapy after thrombolytic therapy of an acute ST-elevation myocardial infarction (STEMI). METHODS AND RESULTS Patients with STEMIExpand
  • 234
  • 13
ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures
a Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD b Department of Radiology, University of California–San Francisco, San Francisco,Expand
  • 193
  • 12
Myocardial Energetics and Efficiency: Current Status of the Noninvasive Approach
The heart is an aerobic organ that relies almost exclusively on the aerobic oxidation of substrates for generation of energy. Consequently, there is close coupling between myocardial oxygenExpand
  • 147
  • 10
Myocardial efficiency during levosimendan infusion in congestive heart failure
Levosimendan, a novel calcium‐dependent calcium sensitizer of the myocardial contractile proteins, also enhances diastolic relaxation and induces peripheral vasodilation by opening potassiumExpand
  • 223
  • 9
Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions.
Encouraged by the clinical success of cardiac resynchronization therapy (CRT), the implantation rate has increased exponentially, although several limitations and unresolved issues of CRT have beenExpand
  • 201
  • 9
Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy
Background— The anti-ischemic agent trimetazidine improves ejection fraction in heart failure that is hypothetically linked to inhibitory effects on cardiac free fatty acid (FFA) oxidation. However,Expand
  • 213
  • 9